Literature DB >> 25480655

Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.

F Guidoccio1, M Grosso, A Antonelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25480655     DOI： 10.1007/s12020-014-0485-6

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  4 in total

1.  The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.

Authors:  Silvia Park; Seung Hwan Moon; Lee Chun Park; Deok Won Hwang; Jun Ho Ji; Chi Hoon Maeng; Su-Hee Cho; Hee Kyung Ahn; Ji Yean Lee; Seok Jin Kim; Joon Young Choi; Won Seog Kim
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

2.  Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.

Authors:  Pedro W Rosario; Gabriela F Mourão; Thassio L Siman; Maria R Calsolari
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

3.  FDG PET/CT in the detection of metastases in a patient with Tg and 131I WBS negative follicular thyroid cancer.

Authors:  Anar Aliyev; Sabire Ylmaz; Meftune Ozhan; Sertac Asa; Metin Halac
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

Review 4.  FDG-PET/CT in lymphoma.

Authors:  Malik E Juweid
Journal:  Methods Mol Biol       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.